ORCERITY Trademark

Trademark Overview

On Thursday, August 5, 2021, a trademark application was filed for ORCERITY with the United States Patent and Trademark Office. The USPTO has given the ORCERITY trademark a serial number of 90866479. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by Pfizer Inc.. The ORCERITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
orcerity

General Information

Serial Number90866479
Word MarkORCERITY
Filing DateThursday, August 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 9, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 2, 2022ASSIGNED TO EXAMINER
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 3, 2023SOU EXTENSION 1 FILED
Tuesday, January 3, 2023SOU EXTENSION 1 GRANTED
Tuesday, January 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 3, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 22, 2023SOU EXTENSION 3 FILED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 5, 2023SOU EXTENSION 2 FILED
Wednesday, July 5, 2023SOU EXTENSION 2 GRANTED
Friday, July 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 22, 2023SOU EXTENSION 3 GRANTED
Tuesday, December 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER

Related Keywords

orcerity preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone